MediMabBio is a ground-breaking biotherapeutic company focusing on the generation of novel immunotherapies for the treatment of cancer. Our discovery platform uses advances in systems biology combined with sophisticated immunological solutions to identify significantly improved first-in-class immuno-oncology drugs that can actively target a range of advanced and solid tumors. The company has developed a pipeline of highly promising novel drugs that aims to overcome the current limitations of cancer immunotherapy. For this purpose, MediMabBio has established collaborations with core partners of academic, R&D institutions and clinical groups in US, UK, Germany, China and Korea.
| Website | http://www.medimabbio.com |
| Employees | 10 (7 on RocketReach) |
| Founded | 2017 |
| Address | #721, 54, Changeop-ro, Sujeong-gu, Seongnam-si, Gyeonggi-do 13449, KR |
| Phone | +82 31-623-2100 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+4 more
(view full list)
|
| Industry | Biotechnology, Drug Discovery |
| Keywords | Immunotherapy, Cancer Treatment, Biotherapeutics, Novel Therapies, Oncology, Systems Biology, Drug Discovery, Biotechnology, Pharmaceutical, Therapeutic Antibodies, Cancer Research, Clinical Trials, Precision Medicine, Biopharma, Therapeutic Development, Immuno-Oncology, Molecular Biology, New Drugs, Health |
| Competitors | Johnson & Johnson, Roche, Novartis, AbbVie, Merck & Co., Inc., Pfizer, GSK, Genentech, Amgen, Biogen +41 more (view full list) |
Looking for a particular MediMabBio employee's phone or email?
MediMabBio Questions
Hongseok Jo is the Founder of MediMabBio.
7 people are employed at MediMabBio.
MediMabBio is based in Seongnam-si, Gyeonggi-do.
Top MediMabBio Employees
-
Hongseok Jo
Founder at MediMabBio
South Korea1 -
12
-
Eunok Kang
COO at MediMabBio
South Korea1 -
Kyoung P
Chief Discovery Officer at MediMabBio
South Korea -
Jeongtek Kim
Manager Business Management at MediMabBio
Seongnam-si, KR1 -
Jeong-Kook Kim
Director. Ph.D at MediMabBio
South Korea
Related Companies
